Taro Pharma, the US-based unit of India's largest drug manufacturer Sun Pharmaceuticals Ltd., has entered into an agreement with Canada-based biotech company Antibe Therapeutics. Following the development, Sun Pharmaceuticals has agreed to acquire 100% stake in Antibe Therapeutics. The acquisition will likely be completed by March 7, 2025, the company said.
Open FlipHomegrown private equity firm Kedaara Capital has begun the new year with its maiden bet in the data analytics and AI solutions segment. The PE firm said Thursday it has invested over $350 million (Rs 3,026 crore) in US-headquartered Impetus Technologies, which has six offices in India. It didn’t disclose the size of the stake it will get in Impetus.
Open FlipShares of the State Bank of India (SBI) rose by nearly 2 per cent during Thursday's trading session following the announcement of the date for releasing its quarterly financial results for the period ending December 31, 2024. SBI stock gained for the third consecutive session today. The share price rallied over 2.15 per cent in the last five sessions.
Open Flip